PANCREAS ADENOCARCINOMA
Clinical trials for PANCREAS ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new PANCREAS ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for PANCREAS ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental drug combo for pancreatic cancer shows early promise, but trial halted
Disease control TerminatedThis early-phase trial tested a drug called CPI-613 (devimistat) combined with chemotherapy and radiation for people with pancreatic cancer that cannot be surgically removed. The goal was to find the safest dose. Only 8 people took part before the study was stopped. While the app…
Matched conditions: PANCREAS ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Medical College of Wisconsin • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC
-
Liquid biopsy study halted: did it help guide cancer care?
Knowledge-focused TerminatedThis study aimed to see if a simple blood test (liquid biopsy) could help doctors make better treatment decisions for people with advanced cancers of the colon, pancreas, or bile duct. Researchers planned to enroll about 130 participants but stopped early with only 16 enrolled. T…
Matched conditions: PANCREAS ADENOCARCINOMA
Sponsor: Oslo University Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:00 UTC